Multi-omics Market Analysis

End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies)

By 2036, academic & research institutes segment is estimated to capture over 60% multi-omics market share. Over the projected time, it is expected that a rise in studies and research centered on multi-omics approaches such as transcriptomics, proteomics, metabolomics, and genomics will propel the segment's expansion. Additionally, funds and investments are being provided to this segment in order to carry out research in this area.

For example, the Multi-omics for Health and Disease Consortium was founded in September 2023 by the National Institutes of Health, which also funded USD 50.3 million for multi-omics research. Professionals from a number of universities, including Washington University, Columbia University, and the University of California, are part of this consortium.

Application (Cell Biology, Oncology, Neurology, Immunology)

During 2024-2036, oncology segment in the multi-omics market is anticipated to grow at more than 18.1% CAGR. Growth in this market is expected to be driven by the increasing prevalence of cancer and the expanding application of multi-omics for cancer. Numerous initiatives are being made by businesses and researchers to use multi-omics techniques to aid cancer sufferers. For example, the biotech startup Freenome initiated the Sanderson Study in September 2022, utilizing real-world data and its multiomics platform to detect certain malignancies. Segment growth is further supported by strategic expenditures made by major players in cancer research.

Product & Service (Products {Instruments, Consumables, Software}, Services)

In multi-omics market, products segment is poised to cross USD 1.8 Billion by the end of 2036. The increasing number of product launches and the spike in developments are expected to fuel the segment's expansion. Businesses are collaborating to innovate and develop new tools and platforms for multiomic research and analysis. For example, Bio-Techne and Lunaphore announced in April 2023 that they would be working together to build a fully automated spatial multiomics solution.

Over the course of the projection period, these developments are anticipated to support the segment's growth in multi-omics market. Furthermore, the creation of more effective, user-friendly goods as a result of technical improvements has improved accessibility for researchers.

Our in-depth analysis of the multi-omics market includes the following segments: